Within days of launching, the company says it heard from nearly 50 prospective customers.
That approach improves interpretability, reduces unnecessary escalation, and keeps the work anchored in a research-only context where safety controls and documentation are part of the protocol, not an afterthought
Annessi G, Cattaruzza MS, Abeni D, Baliva G, Laurenza M, Macchini V et al
Injections: Injections bypass the digestive system, leading to faster absorption and potentially more noticeable effects in a shorter time frame
The figures mentioned here are reflective of the date of writing and may be subject to adjustment
These dose adjustments may be based on: Slower or faster than expected weight loss Digestive issues that make higher doses hard to tolerate Pre-existing conditions like gastroparesis or reflux High sensitivity to medications in general GLP-1 microdosing: Side effects and safety considerations Its normal to experience some side effects when starting a GLP-1